Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Radiology Case Reports|August 23, 2017
Metachronous presentation of small-cell rectal carcinoma on an 18F-FDG PET/CT follow-up for follicular lymphomaYousuf Qaseem, Joanna Fair, Sanaz Behnia, et al.
Radiology Case Reports|February 24, 2017
Calciphylaxis on bone scan: correlation between molecular and cross-sectional findingsMalak Itani, Manuela Matesan, Sanaz Behnia, et al.
Current Problems in Diagnostic Radiology|August 29, 2017
Review of Extraskeletal Activity on Tc-99m Methylene Diphosphonate Bone Scintigraphy and Value of Cross-Sectional and SPECT-CT Imaging CorrelationMohammed Bermo, Sanaz Behnia, Joanna Fair, et al.
Journal of the American Academy of Dermatology|July 25, 2020
Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patientsNeha Singh, Nora A Alexander, Kristina Lachance, et al.
Respiratory Medicine|September 26, 2018
Cardiac sarcoidosis: Diagnosis confirmation by bronchoalveolar lavage and lung biopsyBradley J Petek, David G Rosenthal, Kristen K Patton, et al.
Medical Physics|October 23, 2025
Consistent performance between medical experts and non-expert readers in forced-choice lesion-detection tasks with PET imagesCraig K Abbey, Sangtae Ahn, Muhan Shao, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 28, 2020
Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell LymphomaSolomon A Graf, Ryan D Cassaday, Karolyn Morris, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2024
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177Lu-PSMA-617: Importance of 18F-FDG-Avid Discordant FindingsRidvan Arda Demirci, Alireza Ghodsi, Roman Gulati, et al.
Hematological Oncology|September 20, 2014
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative statusMaika Onishi, Solomon A Graf, Leona Holmberg, et al.
The Lancet. Haematology|July 30, 2021
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 studyRyan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
Pageof 1